Smoking and Inflammation: How Tobacco Alters CRP, HDL and White Blood Cells

Published: June 2025

Smoking increases CRP and WBCs while lowering HDL cholesterol. Understand how quitting impacts your inflammation, immune system, and cardiovascular biomarkers.

← Back to Blog

Every cigarette leaves a mark — not just on your lungs, but in your blood. Smoking is known to elevate C-reactive protein (CRP), especially hs-CRP, due to oxidative stress and immune activation [Nature].

Frequent smokers often have raised white blood cell (WBC) counts, especially neutrophils, and show signs of chronic low-grade inflammation. Alongside this, tobacco use is consistently linked to worse lipid profiles — higher LDL, higher triglycerides, and significantly lower HDL cholesterol [PACE-CME].

The damage isn’t permanent. Upon quitting, CRP and WBC counts tend to fall, while HDL cholesterol rebounds — often reaching levels similar to nonsmokers within 1–2 years.

💡 Practical Takeaways:

Test for these Biomarkers:

hs-CRP, White Blood Cell Count, Neutrophil Count, HDL Cholesterol, LDL Cholesterol, Triglycerides